Publicaciones en las que colabora con Ana Elsa Huerta Hernández (12)

2023

  1. Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset

    European Journal of Clinical Investigation, Vol. 53, Núm. 10

2021

  1. Acquiring sepsis competencies through simulation-based learning bundle during intermediate care unit internship

    Medicine, Vol. 100, Núm. 5, pp. e24483

2017

  1. Lercanidipine-induced chylous ascites: Case report and literature review

    Journal of Clinical Pharmacy and Therapeutics, Vol. 42, Núm. 5, pp. 638-641

2016

  1. Comment on "Retrospective evaluation of prognostic score performances in cirrhotic patients admitted to an intermediate care unit" by Benoît Dupont et al. [Digestive and Liver Disease 2015;47:675-81]

    Digestive and Liver Disease

  2. Enterococcal bloodstream infection. Design and validation of a mortality prediction rule

    International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 147-155

  3. The neutrophil-to-lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects

    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, Vol. 36, Núm. 4, pp. 397-403

  4. The neutrophil-to-lymphocyte ratio as a marker of systemic endothelial dysfunction in asymptomatic subjects

    Nefrologia, Vol. 36, Núm. 4, pp. 397-403

2015

  1. Design and performance of a new severity score for intermediate care

    PLoS ONE, Vol. 10, Núm. 6

  2. Mortality prediction in patients Undergoing Non-invasive ventilation in intermediate care

    PLoS ONE, Vol. 10, Núm. 10

2014

  1. Monitoring of everolimus trough concentrations for achieving optimal tolerance in the management of tuberous sclerosis complex

    Pediatric Neurology

2013

  1. Performance of SAPS II and SAPS 3 in Intermediate Care

    PLoS ONE, Vol. 8, Núm. 10

2011

  1. Relación entre las fases precoces de la enfermedad renal y el síndrome metabólico

    Revista Espanola de Cardiologia, Vol. 64, Núm. 5, pp. 373-378